We are live on ! Find out more
GRCL

Gracell Biotechnologies Inc. American Depositary Shares
GRCL

Delisted

GRCL was delisted on the 21st of February, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Gracell Biotechnologies Inc. American Depositary Shares in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 63 → 0 (-63)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $553M → $0 (-$553M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 63

Holders
–
Holders Change
-63
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
63
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Temasek Holdings
Temasek Holdings
Singapore
-$96.3M
2
VC
Vivo Capital
California
-$95.8M
3
O
OrbiMed
New York
-$93.5M
4
SCM
Sio Capital Management
New York
-$50.2M
5
TCM
TCG Crossover Management
California
-$45.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
– -$1.26M -125,681 Closed
WAM
27
Weiss Asset Management
Massachusetts
– -$1.1M -109,400 Closed
Two Sigma Investments
28
Two Sigma Investments
New York
– -$879K -87,598 Closed
CL
29
CSS LLC
Illinois
– -$733K -73,000 Closed
Invesco
30
Invesco
Georgia
– -$631K -62,863 Closed
CSS
31
Cubist Systematic Strategies
Connecticut
– -$593K -59,063 Closed
FLC
32
Fifth Lane Capital
Texas
– -$586K -58,336 Closed
Citadel Advisors
33
Citadel Advisors
Florida
– -$580K -57,801 Closed
JC
34
JBF Capital
Colorado
– -$502K -50,000 Closed
PAMP
35
Polar Asset Management Partners
Ontario, Canada
– -$502K -50,000 Closed
Pathstone Holdings
36
Pathstone Holdings
New Jersey
– -$494K -49,158 Closed
Geode Capital Management
37
Geode Capital Management
Massachusetts
– -$435K -43,334 Closed
EAM
38
Exome Asset Management
New York
– -$411K -40,974 Closed
PCM
39
Prelude Capital Management
New York
– -$411K -40,974 Closed
GF
40
Gabelli Funds
New York
– -$400K -39,850 Closed
Renaissance Technologies
41
Renaissance Technologies
New York
– -$395K -39,300 Closed
GCIA
42
Gabelli & Co Investment Advisers
New York
– -$344K -34,300 Closed
Two Sigma Advisers
43
Two Sigma Advisers
New York
– -$337K -33,600 Closed
GS
44
GTS Securities
New York
– -$252K -25,144 Closed
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
– -$251K -25,030 Closed
OMC
46
Oasis Management Company
Cayman Islands
– -$251K -25,000 Closed
PCM
47
PenderFund Capital Management
British Columbia, Canada
– -$300K -22,570 Closed
YCM
48
Yakira Capital Management
Connecticut
– -$220K -21,924 Closed
Balyasny Asset Management
49
Balyasny Asset Management
Illinois
– -$203K -20,182 Closed
Goldman Sachs
50
Goldman Sachs
New York
– -$182K -18,112 Closed
1
2
3

GRCL Hedge Fund Activity: Q1 2024 in Review

0 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Gracell Biotechnologies Inc. American Depositary Shares (GRCL) for Q1 2024, worth a combined $0 — down 100% from $553M a quarter earlier.

Sellers outnumbered buyers: 63 funds closed out of GRCL and 0 opened new positions — a net loss of 63 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Temasek Holdings, exiting entirely with an estimated $96.3M sold.

  • 0 institutional investors held Gracell Biotechnologies Inc. American Depositary Shares (GRCL) as of Q1 2024, down from 63 in Q4 2023.
  • Funds reported $0 of Gracell Biotechnologies Inc. American Depositary Shares stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Gracell Biotechnologies Inc. American Depositary Shares positions in Q1 2024 and 63 closed out, a net change of -63 holders.
  • The largest Gracell Biotechnologies Inc. American Depositary Shares seller in Q1 2024 was Temasek Holdings, an estimated $96.3M sold.

Based on aggregated 13F filings for Q1 2024.